Impact analysis of DRG payment reform on hospitalization expenses and length of stay for lung cancer inpatients (2019–2023)
While DRG reform serves as an essential resource allocation mechanism, our findings reveal paradoxical outcomes. The implementation showed limited efficacy in reducing aggregate costs and LOS while provoking structural cost shifts marked by escalated diagnostic and pharmaceutical expenditures. These unintended economic consequences may distort clinical practices, potentially compromising both pharmacoeconomic efficiency and service quality.
Authors
- Xiaojuan Ma (ORCID: https://orcid.org/0009-0001-2798-683X)
- Peifeng Liang (ORCID: https://orcid.org/0000-0002-8473-9843)
- Mingbo Chen (ORCID: https://orcid.org/0000-0002-1023-8966)
- Ting Pan (ORCID: https://orcid.org/0000-0001-5377-2117)
- Zhuo Liu (ORCID: https://orcid.org/0000-0002-8495-7955)
- Dongfeng Pan (ORCID: https://orcid.org/0009-0009-9214-0580)
- Yuhui Geng
Institutions
- Harbin Medical University (CN)
- Ningxia Medical University (CN)
- First Affiliated Hospital of Harbin Medical University (CN)
- Ningxia Center for Diseases Prevention and Control (CN)
- The Fourth People's Hospital of Ningxia Hui Autonomous Region (CN)
Publication Details
- Journal
- Frontiers in Health Services
- Published
- 2025-10-03
- DOI
- https://doi.org/10.3389/frhs.2025.1661995
- Citations
- 1
- Primary Topic
- Economic and Financial Impacts of Cancer
- Type
- article
- Field-Weighted Citation Impact
- 3.13